KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Devon Robotics today announced an optional pricing structure for its CytoCare™ robot that eliminates the need for scarce capital funding. Healthcare providers may now acquire CytoCare for $20.00 USD per dose through a creative financing plan that avoids large, “up front” capital expenditures. Included in this simple, fee-per-dose model is the utilization of CytoCare, hardware installation, clinical implementation, interface engineering, all licensing fees and ongoing service and maintenance.
